We re-examined the RNA-Seq data of ccRCC and control samples for SYK transcripts, and found that while SYK was not differentially expressed, it was alternatively spliced in tumors as compared to non-tumor samples in 24 out of 44 (54.5%) studied patients. The gene discussed is SYK; the disease is nonpapillary renal cell carcinoma.